HER2, chromosome 17 polysomy and DNA ploidy status in breast cancer; a translational study

HER2, chromosome 17 polysomy and DNA ploidy status in breast cancer; a translational study

Abstract Breast cancer treatment depends on human epidermal growth factor receptor-2 (HER2) status, which is often determined using dual probe fluorescence in situ hybridisation (FISH). Hereby, also loss and gain of the centromere of chromosome 17 (CEP17) can be observed (HER2 is located on chromoso...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Altuna Halilovic, Dagmar I. Verweij, Annet Simons, Marian J. P. L. Stevens-Kroef, Susan Vermeulen, Janet Elsink, Bastiaan B. J. Tops, Irene Otte-Höller, Jeroen A. W. M. van der Laak, Carlijn van de Water, Oliver B. A. Boelens, Margrethe S. Schlooz-Vries, Jeroen R. Dijkstra, Iris D. Nagtegaal, Jolien Tol, Patricia H. J. van Cleef, Paul N. Span, Peter Bult
Format: article
Langue:EN
Publié: Nature Portfolio 2019
Sujets:
Medicine
R
Science
Q
Accès en ligne:https://doaj.org/article/eccb0d74ba084146a4c3d5d34a19dea5
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Documents similaires